These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24459828)

  • 1. The influence of toll-like receptor stimulation on expression of EBV lytic genes.
    Siennicka J; Trzcińska A; Cześcik A; Dunal-Szczepaniak M; Lagosz B
    Pol J Microbiol; 2013; 62(3):237-42. PubMed ID: 24459828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression.
    Yang EV; Webster Marketon JI; Chen M; Lo KW; Kim SJ; Glaser R
    Brain Behav Immun; 2010 Oct; 24(7):1089-96. PubMed ID: 20466055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
    PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raji, P3HR-1 and Namalwa cells as a model for the study of Epstein-Barr virus (EBV) reactivation].
    Rek O; Cześcik A; Trzcińska A; Siennicka J
    Med Dosw Mikrobiol; 2010; 62(3):263-9. PubMed ID: 21114019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
    Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
    Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.
    van Gent M; Griffin BD; Berkhoff EG; van Leeuwen D; Boer IG; Buisson M; Hartgers FC; Burmeister WP; Wiertz EJ; Ressing ME
    J Immunol; 2011 Feb; 186(3):1694-702. PubMed ID: 21191071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Epstein-Barr virus and cellular gene expression during the early phases of Epstein-Barr virus lytic induction.
    Auburn H; Zuckerman M; Smith M
    J Med Microbiol; 2016 Nov; 65(11):1243-1252. PubMed ID: 27625030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice.
    Shehab M; Sherri N; Hussein H; Salloum N; Rahal EA
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toll-like receptors expression on Burkitt lymphoma cells].
    Siennicka J; Trzcińska A; Cześcik A; Dunal M
    Med Dosw Mikrobiol; 2011; 63(4):349-54. PubMed ID: 22384669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of latent and lytic transcripts of epstein-barr virus in patients with gastroduodenal diseases: a study from northern India.
    Shukla SK; Prasad KN; Tripathi A; Ghoshal UC; Krishnani N; Husain N
    J Med Virol; 2012 Aug; 84(8):1289-97. PubMed ID: 22711358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Epstein-Barr virus reactivation in a modeled spaceflight system.
    Brinley AA; Theriot CA; Nelman-Gonzalez M; Crucian B; Stowe RP; Barrett AD; Pierson DL
    J Cell Biochem; 2013 Mar; 114(3):616-24. PubMed ID: 22991253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H2O2 inhibits BCR-dependent immediate early induction of EBV genes in Burkitt's lymphoma cells.
    Osipova-Goldberg HI; Turchanowa LV; Adler B; Pfeilschifter JM
    Free Radic Biol Med; 2009 Oct; 47(8):1120-9. PubMed ID: 19540913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encyclopedia of EBV-Encoded Lytic Genes: An Update.
    Murata T
    Adv Exp Med Biol; 2018; 1045():395-412. PubMed ID: 29896677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox control of Epstein-Barr virus replication by human thioredoxin/ATL-derived factor: differential regulation of lytic and latent infection.
    Sono H; Teshigawara K; Sasada T; Takagi Y; Nishiyama A; Ohkubo Y; Maeda Y; Tatsumi E; Kanamaru A; Yodoi J
    Antioxid Redox Signal; 1999; 1(2):155-65. PubMed ID: 11228744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The periodontal pathogen Porphyromonas gingivalis induces the Epstein-Barr virus lytic switch transactivator ZEBRA by histone modification.
    Imai K; Inoue H; Tamura M; Cueno ME; Inoue H; Takeichi O; Kusama K; Saito I; Ochiai K
    Biochimie; 2012 Mar; 94(3):839-46. PubMed ID: 22178321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.